FindTrial
Sign In

Population Pharmacokinetic Study for Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome

Population Pharmacokinetic Study for Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022943
Enrollment
Unknown
Registered
2019-05-04
Start date
2019-05-03
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome

Interventions

Case Series:Tacrolimus

Sponsors

Children's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with PNS younger than 18 years old stabilized on the same dose of TAC for = 3 days were included.

Exclusion criteria

Exclusion criteria: Patients with serious infections or multiple organ injuries were excluded. Patients co-administered traditional Chinese medicines that might affect TAC concentrations were also excluded.

Design outcomes

Primary

MeasureTime frame
population pharmacokinetics;—

Countries

China

Contacts

Public ContactLingfei Huang

Children's Hospital, Zhejiang University School of Medicine

chhlf@zju.edu.cn+86 571 86670410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026